Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Midamine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 16 USDMF, 3 JDMF, 5 EU WC, 13 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

103 FDF Dossiers, 45 FDA Orange Book, 44 Europe, 10 Canada, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 4 Gangwal Healthcare, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 3 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 3 Ingredion Pharma Solutions, 1 Kerry, 2 Keval Exports, 7 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 14 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders, 15 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 14 Direct Compression, 11 Co-Processed Excipients, 11 Thickeners and Stabilizers, 11 Granulation, 7 Taste Masking, 6 Chewable & Orodispersible Aids, 5 Controlled & Modified Release, 5 Coating Systems & Additives, 3 Emulsifying Agents, 2 Rheology Modifiers, 2 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents, 1 API Stability Enhancers, 1 Topical

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 8 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

15 APIs, 10 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 Others

4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/03/2026	Laboratori Alchemia Srl	Italy	LABORATORI ALCHEMIA SRL	221MF10211	MIDODRINE HYDROCHLORIDE	2009-09-28	2016-10-21	Via San Faustino, 68 20134 MILANO-Italy
31/03/2026	Ohara Pharmaceutical	Japan	Ohara Pharmaceutical Co., Ltd.	217MF11229	Off-label use: Midodrine hydrochloride (for manufacturi...	2005-12-12	2008-10-10	121-15 Torii-no, Koka-cho, Koka City, Shiga Prefecture

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Midamine

Midamine

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers

16 USDMF

3 JDMF

5 EU WC

13 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

103 FDF Dossiers

45 FDA Orange Book

44 Europe

10 Canada

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

4 Gangwal Healthcare

1 Dr. Paul Lohmann GmbH & Co. KGaA

1 Aeon Procare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

3 DFE Pharma

5 Gangwal Chemicals

1 Ideal Cures

3 Ingredion Pharma Solutions

1 Kerry

2 Keval Exports

7 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

14 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

31 Fillers, Diluents & Binders

15 Disintegrants & Superdisintegrants

14 Lubricants & Glidants

14 Direct Compression

11 Co-Processed Excipients

11 Thickeners and Stabilizers

11 Granulation

7 Taste Masking

6 Chewable & Orodispersible Aids

5 Controlled & Modified Release

5 Coating Systems & Additives

3 Emulsifying Agents

2 Rheology Modifiers

2 Film Formers & Plasticizers

1 Surfactant & Foaming Agents

1 API Stability Enhancers

1 Topical

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

8 News #PharmaBuzz

GLOBAL SALES INFORMATION

16 US Medicaid Prescriptions

8 Regulatory FDF Prices

MARKET PLACE

15 APIs

10 FDF Dossiers

REF. STANDARDS & IMPURITIES

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons